The effect of CCL19 on vaccine-induced T-cell responses and anti-tumor efficacy was assessed in the CT26 syngeneic tumor model.<h4>Results</h4>CCL19 retained its key biological functions when fused to cancer neoantigens, including CCR7-dependent signaling and chemotaxis of dendritic cells. This evidence concerns the gene CCL19 and neoplasm.